[HTML][HTML] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers withdrawal is associated with higher mortality in hospitalized patients with COVID …

…, J Bascunana, M Rubio-Rivas, S Pintos Otero… - Journal of Clinical …, 2021 - mdpi.com
Our main aim was to describe the effect on the severity of ACEI (angiotensin-converting
enzyme inhibitor) and ARB (angiotensin II receptor blocker) during COVID-19 hospitalization. A …

Effect of in-hospital treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on mortality and complications in patients …

…, CRH Gil, J Bascunana, M Rubio-Rivas, SP Otero… - medRxiv, 2021 - medrxiv.org
Background The use of ACEI (Angiotensin-Converting Enzyme Inhibitor) and ARB (Angiotensin
II Receptor Blocker) in COVID-19 remains controversial. Our main aim was to describe …

[HTML][HTML] Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry

JM Casas-Rojo, JM Antón-Santos… - Revista Clínica …, 2020 - Elsevier
Background Spain has been one of the countries most affected by the COVID-19 pandemic.
Objective To create a registry of patients with COVID-19 hospitalized in Spain in order to …

[HTML][HTML] Prior treatment with statins is associated with improved outcomes of patients with COVID-19: data from the SEMI-COVID-19 Registry

JD Torres-Peña, LM Pérez-Belmonte… - Drugs, 2021 - Springer
Background The impact of statins on COVID-19 outcomes is important given the high
prevalence of their use among individuals at risk for severe COVID-19. Our aim is to assess …

[HTML][HTML] Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study

J Lora-Tamayo, G Maestro, A Lalueza… - The Journal of …, 2021 - ncbi.nlm.nih.gov
Outcomes for patients with COVID-19 infection have been widely reported for the initial peak
of the pandemic. 1 However, there is a lack of data describing outcomes and characteristics …

Patients with COPD hospitalized due to COVID-19 in Spain: a comparison between the first and second wave

M Gómez-Antúnez, A Muiño-Míguez… - Revista Clínica …, 2023 - Elsevier
Objective This work aimed to compare the characteristics, progress, and prognosis of
patients with COPD hospitalized due to COVID-19 in Spain in the first wave with those of the …

[HTML][HTML] Autoimmune diseases and COVID-19 as risk factors for poor outcomes: data on 13,940 hospitalized patients from the Spanish nationwide SEMI-COVID-19 …

MM Ayala Gutierrez, M Rubio-Rivas… - Journal of clinical …, 2021 - mdpi.com
(1) Objectives: To describe the clinical characteristics and clinical course of hospitalized
patients with COVID-19 and autoimmune diseases (ADs) compared to the general population. (2…

Impact of days elapsed from the onset of symptoms to hospitalization in COVID-19 in-hospital mortality: time matters

GM de la Calle, AG Reyne, J Lora-Tamayo… - Revista Clínica …, 2023 - Elsevier
Background COVID-19 shows different clinical and pathophysiological stages over time.
The effect of days elapsed from the onset of symptoms (DEOS) to hospitalization on COVID-19 …

[HTML][HTML] Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

JM Casas-Rojo, JM Antón-Santos… - Scientific Reports, 2023 - nature.com
In 2020, the COVID-19 pandemic followed a two-wave pattern in most countries. Hospital
admission for COVID-19 in one wave or another could have affected mortality, especially …

[HTML][HTML] Risk categories in COVID-19 based on degrees of inflammation: data on more than 17,000 patients from the Spanish SEMI-COVID-19 Registry

…, AM Álvarez Suárez, J Abadía-Otero… - Journal of Clinical …, 2021 - mdpi.com
(1) Background: The inflammation or cytokine storm that accompanies COVID-19 marks the
prognosis. This study aimed to identify three risk categories based on inflammatory …